Evidence map›Paper›PMID 42141888›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Large outbreak of group B invasive meningococcal disease in young adults in South East England, March 2026.

Jessica I'Anson, Charlotte Anderson, Shona Arora, Ray Borrow, Neil Bray, Helen Campbell, Colin Nj Campbell, Meera Chand, Stephen A Clark, Paul Crook and 31 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Jessica I'AnsonUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Charlotte AndersonUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Shona AroraUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Ray BorrowUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Neil BrayUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Helen CampbellUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Colin Nj CampbellUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Meera ChandUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Stephen A ClarkUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Paul CrookUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Obaghe EdeghereUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Stephen GlassEast Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom.
Anjan GhoshKent County Council, Maidstone, United Kingdom.
Natalie GrovesUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Florence HalfordUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Kirsty HewittUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Susan HopkinsUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Rachael HornigoldUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Reece JarrattUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Merav KlinerUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Nefeli KouppaUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Shamez N LadhaniSt George's University, London, United Kingdom.
Jay LucidarmeUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Shobha LuxmiEast Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom.
Martin Cj MaidenUniversity of Oxford, Oxford, United Kingdom.
Eve MatthewsUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Rachel MearkleUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Charlotte MirrieleesUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Jaime MorganUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Samuel MosesEast Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom.
Rich MyersUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Grace OswaldUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Steven RileyUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
David J RobertsUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Charlene Mc RodriguesLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Clare SawyerUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Matthew StruttEast Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom.
Ed WallerKent and Medway Integrated Care Board (ICB), Maidstone, United Kingdom.
William WelfareUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Trish MannesUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Incident Management TeamMembers of the Incident Management Team are listed under Acknowledgements.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An unusually large outbreak of invasive meningococcal disease affecting young adults occurred in South East England between 13 and 18 March 2026, with 21 confirmed cases including two fatalities. Thirteen cases were university students and 19 had attended the same nightclub over a 3-day period. The outbreak strain was a distinct genome within the previously seen type B: P1.12-1,16-183: F1-5: ST-485 (cc41/44). Over 13,000 chemoprophylaxis doses and 11,000 meningococcal B vaccinations were provided to possible contacts.

Indexed as

Disease OutbreaksMeningococcal InfectionsMeningococcal VaccinesNeisseria meningitidis, Serogroup BAdolescentAdultEnglandFemaleHumansMaleVaccinationYoung AdultMeningococcal Vaccinesbacterial infectionsepidemiologyImmunisationinfectious diseasesinvasive meningococcal diseaseMeningococcalmeningococcal diseaseNeisseria meningitidisoutbreakoutbreak controlpublic healthvaccinationvaccine preventable diseasesvaccines and immunisation

Identifiers

PMID42141888
PMCPMC13090753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.